Clearside Biomedical Inc
Biotechnology
Healthcare
CLSD
5.19 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
4.45
52 week high
4.39
high
4.57
52 week low
0.00
low
3.96
growth
5.32 %
previous Close
4.39
P/E ratio
market cap
18.69 M
div yield
0
usd
Jun 2025
qoq
revenue
492 K
-78.88 %
net incoming
-4.50 M
45.34 %
eps
0.00 %
9.09 %
eps surprise
2.82 %
net profit margin
-913.62 %
-560.00 %
operating incoming
-3.57 M
31.45 %
net change in cash
-4.25 M
33.48 %
cash on hand
9.38 M
-31.20 %
cost of revenue
84.00 K
-66.13 %
top top